×
English
हिंदी
ગુજરાતી
Home
My Feed
Remove Ads
Get Premium Content
Go Pro @₹99
Credit Cards
Instant Loans
Apply Now
Credit Score
Refer & Earn ₹500
Refer Now
Finance Tracker
Learning Curve
Fixed Deposits
Business Loan
Markets
Markets
FII & DII Activity
Corporate Action
Research Advice
Earnings
Technical Trends
Stock Deals
Intraday Large Deals
Bonds
Webinar
Pre Market
Stock Scanner
Sector Analysis
Unlisted Shares
Stock Updates
PRO Stock Lists
Monsoon Tracker
Seasonality Analysis
Crypto Dashboard
Web Stories
Tax Calculator
Forum
Gold Rate
Silver Rate
IFSC Code Finder
Storyboard18
IPO
Economic Indicators
Economic Calendar
Global Markets
US Markets
ETFs
Indian Indices
News
News
Tech/Startups
Auto
Research
Opinion
Politics
Personal Finance
EPF Guide
Real Estate
Portfolio
Watchlist
Personal Finance
Personal Finance
Loans
Fixed Deposit Comparison
Fixed Deposit Interest Calculator
Moneycontrol - SecureNow Health Insurance ratings
Mutual Funds
Mutual Funds
Performance Tracker
Top ranked funds
My Portfolio
Top performing Categories
Forum
New Fund Offers
MF Simplified
Commodities
Mutual Funds
Gold Rate
Silver Rate
Currencies
Cryptocurrency
Media
Live TV & Shows
Video
Podcast
Photos
Invest Now
Trade like Experts
Invest in Unlisted Shares
Specials
Pharma Industry Conclave
Unlocking opportunities in Metal and Mining
#MFSummit2025
Moneycontrol mutual fund summit 2025
Advanced Technical Charts
International
Get App
Be a
Pro
Home
PRO
Markets
News
Editor’s Picks
Tech
India
Learning Curve
Portfolio
Watchlist
Commodities
MF
Personal Finance
Forum
Videos
you are here:
Home
News
Dr Lal Path Labs
Dr Lal Path Labs
Ads
Stocks to Watch Today: Coforge, NCC, Kotak Bank, GPT Infra, Vikran Engineering, Eclerx, Container Corporation, RailTel, Thyrocare, IOC in focus on 27 October
Dr Lal PathLabs: Exit of a company veteran stokes investor concerns
Dr Lal PathLabs shares shed 6% amid profit booking after firm's Q2 net profit jumps 18%
Dr Lal PathLabs Q1 profit up 29% at Rs 108 cr
Can Dr Lal PathLabs, Metropolis brave competition from new-age diagnostic rivals?
Dr Lal PathLabs jumps 5% on double upgrade from Kotak Institutional Equities
Bonanza Portfolio's top stock picks amid ongoing market slump; check here
Why Dr Lal PathLabs’ fat profit margins are bringing no cheer
Short Call | Smallcaps on big strides, down swipe on SBI Cards, cracks in Shree Cements, block deals boom
Short Call | Smallcaps make big leaps, IEX in short squeeze, Tata Chem bulls charge, HDFC AMC in pressure
Is network expansion the booster dose diagnostic firms need?
Dr Lal Path Labs Q2 PAT declines 25% to Rs 72.4 crore
Aarti Industries, Dr Lal Path Labs, HDFC AMC rise 2-4% on inclusion in F&O
Home
Markets
Loans
SPIN
2
WIN
News
Portfolio